Thermo Fisher's Q3 earnings boosted by COVID-19 sales

By The Science Advisory Board staff writers

October 21, 2020 -- Products related to the novel coronavirus are spelling success for Thermo Fisher, which reported that revenue was up by 36% in the third quarter to $8.52 billion, compared with $6.27 billion the same period last year.

The company's COVID-19-related revenue amounted to $2 billion in the third quarter, returning its base business to growth, the company reported October 21. Furthermore, third-quarter operating income under generally accepted accounting principles (GAAP) was up to $2.43 billion, compared with $0.95 billion in 2019.

Thermo Fisher's achievements during the latest earnings period include the launches of a product for automating high-throughput polymerase chain reaction (PCR) testing and two COVID-19 antibody tests. The company also noted that it has significantly expanded production of viral transport media in Europe.

With an eye toward continued momentum in the near future, the company said that it is scaling up production of sample collection and laboratory supplies and preparing to support new coronavirus therapies and vaccines being developed by the pharmaceutical industry. Thermo Fisher's laboratory products and services division delivered revenue of $3.11 billion for the third quarter, up from $2.62 billion for the same period of 2019.

Thermo Fisher launches closed cell processing system
Thermo Fisher Scientific has launched the Gibco CTS Rotea counterflow centrifugation system, a modular, closed cell therapy processing system for cell...
Thermo Fisher debuts clinical research grant program
Thermo Fisher Scientific introduced a clinical research grant program to support health projects in oncology and reproductive health.
Thermo Fisher center forms partnerships for biomarkers
Thermo Fisher Scientific announced new collaborations for clinical biomarker discovery among the Thermo Fisher Precision Medicine Science Center, AstraZeneca,...
Thermo Fisher opens new bioprocessing collaboration center
Thermo Fisher Scientific has opened a new bioprocessing collaboration center in St. Louis to accelerate innovations in biologics manufacturing.

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
Lab of the Future USA
May 11-12, 2021
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter